Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Petto

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for PractitionersH Petto, Z Kadziola, M A Belger
Diabetes, Obesity & Metabolism|October 28, 2010
Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et alB Gallwitz, A Haupt, P Kraus, et al.
Current Medical Research and Opinion|September 22, 2007
Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal womenJ D Ringe, G E Christodoulakos, D Mellström, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 20, 2014
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapyB Hofstetter, S Gamsjaeger, F Varga, et al.
Current Medical Research and Opinion|April 12, 2014
Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)O Ljunggren, C L Benhamou, J Dekker, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosisJ J Stepan, D B Burr, J Li, et al.
European Journal of Pain (London, England)|August 28, 2015
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?P Marchettini, S Wilhelm, H Petto, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for PractitionersH Petto, Z Kadziola, M A Belger
Diabetes, Obesity & Metabolism|October 28, 2010
Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et alB Gallwitz, A Haupt, P Kraus, et al.
Current Medical Research and Opinion|September 22, 2007
Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal womenJ D Ringe, G E Christodoulakos, D Mellström, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 20, 2014
Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapyB Hofstetter, S Gamsjaeger, F Varga, et al.
Current Medical Research and Opinion|April 12, 2014
Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)O Ljunggren, C L Benhamou, J Dekker, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 6, 2010
Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosisJ J Stepan, D B Burr, J Li, et al.
European Journal of Pain (London, England)|August 28, 2015
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?P Marchettini, S Wilhelm, H Petto, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Pageof 1